Seoulin Bioscience Market Cap

Seoulin Bioscience has a market cap or net worth of 57.37 billion as of March 20, 2026. Its market cap has decreased by -4.48% in one year.

Market Cap

57.37B

Enterprise Value

36.08B

Revenue

77.09B

Ranking

n/a

PE Ratio

118.18

Stock Price

6,480.00

Market Cap Chart

Since October 25, 2005, Seoulin Bioscience's market cap has decreased from 69.74B to 57.37B, a decrease of -17.74%. That is a compound annual growth rate of -0.95%.

Market Cap History

Date	Market Cap	% Change
Mar 20, 2026	57.37B	-0.15%
Dec 30, 2025	57.46B	-6.51%
Dec 30, 2024	61.46B	-21.97%
Dec 28, 2023	78.77B	-19.25%
Dec 29, 2022	97.55B	-44.18%
Dec 30, 2021	174.75B	62.58%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
3billion	475.15B
Dx & Vx	443.42B
GENINUS	190.11B
Cytogen	108.08B
HLB Panagene	102.31B
Green Cross Medical Science	80.23B
Protia	63.10B
GeneMatrix	42.93B

Market Cap Rankings